Marine Park Holdings

Marine Park Holdings, Inc. was a public shell company and investment vehicle primarily focused on the healthcare and life sciences sectors. Managed by principals from Harborview Capital Management, including David Stefansky and Richard Rosenblum, the company served as a platform for taking private biotechnology and medical technology firms public through reverse merger transactions. In January 2008, Marine Park Holdings completed a significant reverse merger with NewCardio, Inc., a developer of non-invasive cardiac diagnostic technologies, subsequently changing its name to NewCardio, Inc. and trading under the symbol NWCI. The entity was part of a broader strategy by its management to facilitate the public listing and capitalization of emerging healthcare companies.